SEA: pharma market revenue 2028

In 2023, the pharmaceutical market revenue in Southeast Asia amounted to about 12.8 billion U.S. dollars. The region's pharma market was estimated to reach a new peak of around 17.1 billion dollars in revenue in 2028.

Revenue of the pharmaceutical market in Southeast Asia from 2019 to 2023, with forecasts to 2028 (in billion U.S. dollars)

Characteristic	in billion U.S. dollars
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

More information

Supplementary notes

* Forecast

Data provided by Statista Market Insights are estimates.

The Pharmaceuticals market covers remedies used to cure, treat, prevent, and diagnose diseases. These small molecule drugs or biologic medical products may be called drugs, medications, or medicines. Prescription drugs and over-the-counter (OTC) drugs are both included. Depending on the regulations in each country, these products are provided by pharmacies, hospitals, physicians, and/or drug stores, and/or they can be bought elsewhere. They may be administered in the form of pills, capsules, gels, ointments, injections, infusions, lozenges, or aerosols/sprays.

The Pharmaceuticals market is organized in markets that cover drugs used in specific medical fields, i.e., medicines for a specific disesase or a certain type of medicine. They include original brands, biosimilars, generics, and orphan drugs. The Other Pharmaceuticals market provides information on additional specialties that are not covered by the main markets.

Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Novartis, Roche, Pfizer, Merck & Co, Johnson & Johnson, AbbVie, Sanofi

Citation formats